DNA2.0 opens European office
California-based gene synthesis and protein engineering company DNA2.0, is opening its European branch office in Basel, Switzerland.
California-based gene synthesis and protein engineering company DNA2.0, is opening its European branch office in Basel, Switzerland.
The expansion is part of DNA2.0's strategy to serve its clients in both domestic and international markets.
"We are excited to enhance DNA2.0's custom gene synthesis services in the European marketplace," said DNA2.0 Jeremy Minshull.
"We have devoted our energies to building the fastest and most reliable gene synthesis process in the world. Our Basel office will allow us to provide the same PhD-level customer support to our growing European customer base that our US customers already enjoy."
Dr Louise Rafty, director of sales at DNA2.0, said the company's investment in Europe reflected the strong growth it sees in demand for synthetic genes at European biotechnology and pharmaceutical companies as well as its universities.
Rafty added: "Access to fast and accurate gene synthesis is revolutionizing the way scientists think about molecular biology; enabling a number of exciting emerging applications such as codon optimisation, protein engineering, and RNAi resistance."
The company is based in Menlo Park, California.